Ciprofloxacin breakpoints in enteric fever--time to revise our susceptibility criteria.
Rodrigues
C
C
Kumar
N Jai
NJ
Lalwani
J
J
Mehta
A
A
D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007194:India; D008826:Microbial Sensitivity Tests; D010284:Paratyphoid Fever / Q000188:drug therapy / Q000382:microbiology*; D012482:Salmonella paratyphi A / Q000187:drug effects*; D012485:Salmonella typhi / Q000187:drug effects*; D014435:Typhoid Fever / Q000188:drug therapy / Q000382:microbiology*
D002939:Ciprofloxacin